Jonathan Kaufman
Board Member
Lipella Pharmaceuticals Inc. (LIPO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jonathan Kaufman
Jonathan Kaufman is recorded as CEO and Board Member at Lipella Pharmaceuticals Inc. (LIPO). The proxy statement of Lipella Pharmaceuticals Inc. reports total compensation of $323,383 for Jonathan Kaufman in fiscal 2023, including a base salary of $204,133. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2005-01-01–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lipella Pharmaceuticals Inc.
Other people whose current roles at this company are on record from its filings.
- Douglas Johnston CFO
- Daniel Cohen Board Member
- Dr. Lori Birder Board Member
- Lori Birder Board Member
- Ryan Pruchnic Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Lipella Pharmaceuticals Inc. (LIPO) | Chief Executive Officer | $204,133 | $323,383 |
| 2022 | Lipella Pharmaceuticals Inc. (LIPO) | Chief Executive Officer | $183,300 | $913,800 |
| 2021 | Lipella Pharmaceuticals Inc. (LIPO) | Chief Executive Officer | $183,300 | $913,800 |
Recent activity
No call appearances or filed executive changes recorded yet.